Dr. Jason Chua’s research could move new breakthrough treatments into clinical trials—targeting a rare form of Charcot‑Marie‑Tooth disease in children and informing therapies for many other neuropathies.
🔬 Transformative CMT4B3 Discoveries
#MerkinScholars #PatientImpact #CMT #raredisease